|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
|
|---|---|---|---|---|
| Current assets: | ||||
| Cash and cash equivalents | ||||
| Prepaid insurance - current | ||||
| Total current assets | ||||
| Deferred offering costs | ||||
| Prepaid insurance - non-current | ||||
| Marketable securities held in Trust Account | ||||
| Deferred offering costs | ||||
| TOTAL ASSETS | ||||
| LIABILITIES, CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT | ||||
| Current liabilities: | ||||
| Accrued offering costs | ||||
| Accounts payable | ||||
| Accrued expenses | ||||
| Due to related party | ||||
| Promissory note - related party | ||||
| Total current liabilities | ||||
| Deferred underwriting fee payable | ||||
| Advisory fee payable | ||||
| Total Liabilities | ||||
| Class A ordinary shares subject to possible redemption, 34,500,000 shares at redemption value of $10.23 per share at September 30, 2026 | ||||
| Common Class A | ||||
| Total class A ordinary shares subject to possible redemption, 34,500,000 shares at redemption value of $10.23 per share at September 30, 2026 | ||||
| Shareholders’ Deficit | ||||
| Preference shares, $0.0001 par value; 5,000,000 shares authorized; none issued and outstanding at September 30, 2026 and December 31, 2025 | ||||
| Common stock value | ||||
| Common Class A | ||||
| Common Class B | ||||
| Additional paid-in capital | ||||
| Accumulated deficit | ||||
| Total Shareholders’ Deficit | ||||
| TOTAL LIABILITIES CLASS A ORDINARY SHARES SUBJECT TO POSSIBLE REDEMPTION AND SHAREHOLDERS’ DEFICIT |
Loading...